Regulation of the p53 tumor suppressor protein occurs to a large extent through control of protein stability, and the MDM2 protein has been shown to play a key role in targeting p53 for degradation. Stress signals that activate the p53 response lead to stabilization of p53 through inhibition of MDM2 mediated degradation, and it is becoming evident that a number of mechanisms exist to abrogate this activity of MDM2. Other members of the p53 protein family may also be regulated through protein stability, although MDM2 is not responsible for the degradation of p73. Nevertheless, interactions of p63 and p73 with MDM2 or p53 have been described, suggesting that each of the p53-related proteins can play some role in regulating the activity of the others Keywords: p53; p73; p63; MDM2; E2F-1; protein stability Common themes, different players: Regulation of p53, p73 and p63The tumor suppressor protein p53 has been studied intensively over the past decade, and it is clear that p53 activity plays an important role in preventing tumor development. p53 is a potent inhibitor of cell growth and so control of p53 activity is essential during normal growth and development. Regulation of p53 has been described at the level of transcription and translation, 1 and through allosteric regulation of p53 conformation. 2 However, by far the most attention has been directed to modulation of p53 protein stability which appears to be one of the critical mechanism by which p53 function is regulated, and the mechanisms through which p53 is degraded have been under intense scrutiny over the past few years. The recent identification of the p53 related proteins, p63 and p73, has raised the question of whether all the family members are regulated through the same mechanisms to allow for a coordinated response, or whether each protein is subject to independent regulation. This review aims to summarize the present models on how the p53 protein is degraded and how these pathways are inhibited to allow activation of a p53 response, with comparisons to our, as yet, less comprehensive understanding of how p73 and p63 activity is controlled.